The combination therapy of EPA and pitavastatin for regression of coronary plaque evaluated by IB-IVUS ( CHERRY ) study will be the first multicenter study using IB-IVUS to investigate the effects of combination therapy with pitavastatin and EPA on coronary plaque volume and tissue characteristics .